Literature DB >> 9598803

Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.

T Kohno1, M Takahashi, R Manda, J Yokota.   

Abstract

The PTEN/MMAC1/TEP1 gene has been isolated as a tumor suppressor gene that is altered in several types of human tumors including brain, breast, and prostate cancers. In the present study, we report PTEN/MMAC1/TEP1 alterations in human lung cancers. Intragenic homozygous deletions were detected in 6 (40%) of 15 small cell lung carcinoma (SCLC) cell lines and in 2 (8%) of 25 non-small cell lung carcinoma (NSCLC) cell lines. A nonsense mutation and a missense mutation were detected in 2 (8%) NSCLC cell lines. An intragenic homozygous deletion, a 1-bp frameshift mutation, and a nonsense somatic mutation were also detected in three (6%) of 47 surgical specimens. All the lung tumors with PTEN/MMAC1/TEP1 mutations were homozygous for the mutant alleles. These findings suggest that PTEN/MMAC1/TEP1 plays a role as a tumor suppressor gene in the genesis and/or progression of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598803     DOI: 10.1002/(sici)1098-2264(199806)22:2<152::aid-gcc10>3.0.co;2-s

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  40 in total

1.  Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  S Ramaswamy; N Nakamura; F Vazquez; D B Batt; S Perera; T M Roberts; W R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 2.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

Review 3.  Targeting the PI3-kinase/Akt/mTOR signaling pathway.

Authors:  Burhan Hassan; Argun Akcakanat; Ashley M Holder; Funda Meric-Bernstam
Journal:  Surg Oncol Clin N Am       Date:  2013-08-06       Impact factor: 3.495

4.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

Review 5.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

6.  PTEN protein expression in malignant pleural mesothelioma.

Authors:  Vijay Agarwal; Anne Campbell; Kate L Beaumont; Lynn Cawkwell; Michael J Lind
Journal:  Tumour Biol       Date:  2012-12-15

7.  PTEN identified as important risk factor of chronic obstructive pulmonary disease.

Authors:  H Dean Hosgood; Idan Menashe; Xingzhou He; Stephen Chanock; Qing Lan
Journal:  Respir Med       Date:  2009-07-21       Impact factor: 3.415

Review 8.  Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

Authors:  Jaclyn LoPiccolo; Gideon M Blumenthal; Wendy B Bernstein; Phillip A Dennis
Journal:  Drug Resist Updat       Date:  2007-12-31       Impact factor: 18.500

Review 9.  Akt in the pathogenesis of COPD.

Authors:  Steven Bozinovski; Ross Vlahos; Michelle Hansen; Ken Liu; Gary P Anderson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.

Authors:  M Ming; W Han; J Maddox; K Soltani; C R Shea; D M Freeman; Y-Y He
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.